EKO International Corp.
- Jurisdiction
Canada - ISIN
US2685542019 (EKNL )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
Profile
EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. Read full profile
Fundamentals
- Net revenue
€85.30K - Gross margin
-100.0% - EBIT
-€1.51M - EBIT margin
-1,765.0% - Net income
-€1.88M - Net margin
-2,207.3%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions